Sign in
4

Changes in Ownership

PALVELLA THERAPEUTICS, INC. Filed Acc 0001104659-26-076460

Chief Operating Officer sold 4,302 shares at an average $110.73 ($476,373)

  • Chief Operating Officer acquired 4,302 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Goin Kathleen · Chief Operating Officer

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2026-06-17 Exercise or conversion : show line 1 in the form 10b5-1 +2,154 $7.14 $15,380 2,154 D
2026-06-17 Exercise or conversion : show line 2 in the form 10b5-1 +2,148 $9.08 $19,504 4,302 D
2026-06-17 Sale : show line 3 in the form 10b5-1 −2,390 $110.26 $263,520 1,912 D
2026-06-17 Sale : show line 4 in the form 10b5-1 −1,887 $111.31 $210,047 25 D
2026-06-17 Sale : show line 5 in the form 10b5-1 −25 $112.23 $2,806 0 D
Open-market sales · 4,302 sh · avg $110.73 · $476,373

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-06-17 Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (Right to Buy) −2,154 8,627 D
2026-06-17 Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (Right to Buy) −2,148 8,592 D
Loading xslF345X06/tm2618468-1_4seq1.xml…